⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2577998 | 0.73 | ALDH1A1 (0.61) | — | |
| SCHEMBL391121 | 0.73 | ALDH1A1 (0.61) | — | |
| SCHEMBL391122 | 0.73 | ALDH1A1 (0.61) | — | |
| SCHEMBL3373054 | 0.73 | ALDH1A1 (0.61) | — | |
| SCHEMBL2577996 | 0.73 | ALDH1A1 (0.61) | — | |
| SCHEMBL1882464 | 0.73 | ALDH1A1 (0.61) | — | |
| SCHEMBL9679607 | 0.73 | ALDH1A1 (0.61) | — | |
| SCHEMBL5248678 | 0.73 | CYP2A6 (0.57) | — | |
| SCHEMBL9679616 | 0.73 | ALDH1A1 (0.61) | — | |
| SCHEMBL19844176 | 0.73 | KIF11 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9562040-B2 | Processes for preparing Rivaroxaban | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2017-02-07 | — | — | US | claimed |
| EP-2899185-A1 | Processes for preparing linezolid | Indiana University Research and Technology Corporation (US) | 2015-07-29 | — | — | EP | claimed |
| US-20150175590-A1 | PROCESSES FOR PREPARING RIVAROXABAN | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2015-06-25 | — | — | US | claimed |
| EP-2834235-A1 | PROCESSES FOR PREPARING RIVAROXABAN | Indiana University Research and Technology Corporation (US) | 2015-02-11 | — | — | EP | claimed |
| WO-2013152168-A1 | PROCESSES FOR PREPARING RIVAROXABAN | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2013-10-10 | — | — | WO | claimed |
| EP-2563781-A1 | PROCESSES FOR PREPARING LINEZOLID | Indiana University Research and Technology Corporation (US) | 2013-03-06 | — | — | EP | claimed |
| WO-2011137222-A1 | PROCESSES FOR PREPARING LINEZOLID | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2011-11-03 | — | — | WO | claimed |
| WO-2024117179-A1 | KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | ALIVEXIS, INC. (JP) | 2024-06-06 | — | — | WO | disclosed |
| EP-3498705-B1 | 2-ACETYL-6-(2-(2-(4-BROMOBENZYLIDENE)HYDRAZINYL)THIAZOLE-4-YL)-3,7,9-TRIHYDROXY-8,9B-DIMETHYLDIBENZO[B,D]FURAN-1(9BH)-ONE EXHIBITING AN INHIBITORY EFFECT ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME | OBSHESTVO S OGRANICHENNOI OTVETSTVENNOSTJU INNOVATIVE PHARMACOLOGY RES IPHAR (RU) | 2021-01-06 | — | — | EP | disclosed |
| US-10399965-B2 | 2-acetyl-6-(2-(2-(4-bromobenzylidene)hydrazinyl)thiazole-4-yl)-3,7,9-trihydroxy-8,9b-dimethyldibenzo[,b,d]furan-1(9bh)-one exhibiting an inhibitory effect on human tyrosyl-DNA-phosphodiesterase 1 enzyme | Innovative Pharmacology Research OOO (IPHAR) (RU) | 2019-09-03 | — | — | US | disclosed |
| EP-3498705-A1 | 2-ACETYL-6-(2-(2-(4-BROMOBENZYLIDENE)HYDRAZINYL)THIAZOLE-4-YL)-3,7,9-TRIHYDROXY-8,9B-DIMETHYLDIBENZO[B,D]FURAN-1(9BH)-ONE EXHIBITING AN INHIBITORY EFFECT ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME | Obshestvo S Ogranichennoi Otvetstvennostju "Innovatie Pharmacology Research" (IPHAR) (RU) | 2019-06-19 | — | — | EP | disclosed |
| US-20190177315-A1 | 2-ACETYL-6-(2-(2-(4-BROMOBENZYLIDENE)HYDRAZINYL)THIAZOLE-4-YL)-3,7,9-TRIHYDROXY-8,9B-DIMETHYLDIBENZO[B,D]FURAN-1(9BH)-ONE EXHIBITING AN INHIBITORY EFFECT ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME | Innovative Pharmacology Research OOO (IPHAR) (RU) | 2019-06-13 | — | — | US | disclosed |
| US-20190084941-A1 | COMPOUNDS AND METHODS OF TREATING INFECTIONS | NEOCULI PTY LTD (AU) | 2019-03-21 | — | — | US | disclosed |
| US-20110178138-A1 | INHIBITORS OF PROTEIN PRENYLTRANSFERASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-07-21 | — | — | US | disclosed |
| CN-101899075-A | Beta-N-glucosylated-alpha-aminophosphonate compound | UNIV NANKAI | 2010-12-01 | — | — | CN | disclosed |
| WO-2010054279-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION (US) | 2010-05-14 | — | — | WO | disclosed |
| US-20100009992-A1 | AMPK MODULATORS | MERCURY THERAPEUTICS, INC. | 2010-01-14 | — | — | US | disclosed |
| US-6103736-A | SHOWING AN INHIBITORY ACTION ON GASTRIC ACID SECRETION AND A PROTECTIVE ACTION OF GASTRIC MUCOSA; 2-(HETERO)ARYL-3-AMINOIMIDAZO-(2,1-A)ISOQUINOLINES; ANTIULCER AGENTS; | SHINNIPPON PHARMACEUTICAL INC. (JP) | 2000-08-15 | — | — | US | disclosed |
| US-6020342-A | Fused imidazo[1,2-A]pyridines | SHINNIPPON PHARMACEUTICAL, INC. (JP) | 2000-02-01 | — | — | US | disclosed |
| EP-0822194-A1 | FUSED IMIDAZO 1,2-a]PYRIDINES | Shinnippon Pharmaceutical Inc. (JP) | 1998-02-04 | — | — | EP | disclosed |